Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age

Sponsor
Taipei Medical University WanFang Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01826357
Collaborator
(none)
700
1
11.1
63.2

Study Details

Study Description

Brief Summary

The metabolic syndrome (MetS) is a cluster of clinical indices that signals increased risk for cardiovascular disease and Type 2 diabetes. Women with polycystic ovary syndrome (PCOS) were associated with MetS and insulin resistance. Cluster analysis was a useful tool for identifying groups of women sharing similar metabolic risk factor patterns. Oligomenorrhea, hyperandrogenism and polycystic ovary morphology were the three major components of PCOS. Obesity is a main risk factor in metabolic syndrome. the investigators are interesting to evaluate the relationship between risk of metabolic syndrome and their clinical and/or biochemical characteristics in women with reproductive age.

Design: Retrospective study; medical records reviewed. Participants and setting: The investigators retrospectively reviewed the medical records of female patients who visited our Reproductive Endocrinology Clinic from Jan. 1, 2009 to Jun. 31, 2012.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Definitions of the metabolic syndrome based on arbitrary cutoff points for several quantitative variables, where each variable is related linearly to cardiovascular risk. Even consensual definitions differ between international authorities and continue to change. Moreover, such cutoff s should be gender and ethic difference. Cluster analysis is a statistical method base on algorithms, which seek to minimize within-group variation and maximize between-group variation for the clustering variables. This technique is suitable for defining groups, reflecting the natural structure of data without relying on inappropriate arbitrary cutoffs. We conduct this retrospective study to review the medical records of female patients who visited our Reproductive Endocrinology Clinic from Jan. 1, 2009 to Dec. 31, 2012. Cluster analysis was performed in our studied cases to evaluate the correlation between clinical/biochemical characteristic and risk of metabolic risk in women with reproductive age.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    700 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age.
    Study Start Date :
    Mar 1, 2013
    Anticipated Primary Completion Date :
    Feb 1, 2014
    Anticipated Study Completion Date :
    Feb 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. metabolic syndrome [Retrospectively reviewed the patients who visited Reproductive Endocrinology Clinic from Jan. 1, 2009 to Jun. 31, 2012.]

      We conduct this retrospective study by using cluster analysis, to investigate the relationship between metabolic complications and biochemical/clinical characteristics of endocrinologic dysfunction in women with reproductive age.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years to 48 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Women had been fulfilled with whole anthropometric measurements, clinic and biochemical survey about cardiovascular study.

    Exclusion Criteria:
    1. women who had been diagnosed with malignant tumor, Asherman's syndrome, Mullerian agenesis, and chromosomal anomalies;

    2. women who had had menarche less than 1 years before evaluation or who were older than 49;

    3. women who received hormones or drugs for major medical diseases within three months of blood sampling.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 WanFang Medical Center at Taipei Medical University Taipei City Taiwan 116

    Sponsors and Collaborators

    • Taipei Medical University WanFang Hospital

    Investigators

    • Principal Investigator: Ming I Hsu, MD, WanFang Medical Center at Taipei Medical University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ming-I Hsu, Taipei Medical University WanFang Hospital, Taipei Medical University WanFang Hospital
    ClinicalTrials.gov Identifier:
    NCT01826357
    Other Study ID Numbers:
    • Hsu2013-TMU-JIRB 201302002
    First Posted:
    Apr 8, 2013
    Last Update Posted:
    Nov 6, 2013
    Last Verified:
    Nov 1, 2013
    Keywords provided by Ming-I Hsu, Taipei Medical University WanFang Hospital, Taipei Medical University WanFang Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 6, 2013